Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 13

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 13
---
, however, will pay any commissions or other fees payable to brokers or dealers in connection
with any sale of the common stock.

<div align='center'>6

LEGAL MATTERS</div>

The validity of the common stock has been passed
upon by Sichenzia Ross Ference Carmel LLP, New York, New York.

<div align='center'>EXPERTS</div>

The consolidated financial statements of INmune
Bio Inc. as of and for the years ended December 31, 2024 and 2023 appearing in INmune Bio Inc.’s Annual Report on Form 10-K for
the year ended December 31, 2024, have been audited by Marcum LLP, as set forth in its report thereon, included therein, and incorporated
herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on
the authority of such firm as experts in accounting and auditing.

<div align='center'>INCORPORATION OF CERTAIN DOCUMENTS by Reference</div>

The SEC, allows us to incorporate by reference
certain of our publicly filed documents into this reoffer prospectus, which means that such information is considered part of this reoffer
prospectus. Information that we file with the SEC subsequent to the date of this reoffer prospectus will automatically update and supersede
this information. We incorporate by reference the documents listed below and any future filings made with the SEC under all documents
subsequently filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act until the selling stockholders have sold all
of the shares offered hereby or such shares have been deregistered.

| ● | The                                                                                                                       
 description of our common stock contained in our Registration Statement on Form                                           
 8-A filed with the SEC on February 1, 2019 (File                                                                          
 No. 001-38793), including any amendment or report filed for the purpose of updating such description. In addition, a Form 
 8-A filed on December 30, 2020, contains a description                                                                    
 of certain rights attributable to the common stock.                                                                       |

Notwithstanding the foregoing, information furnished
under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated by reference in this
Registration Statement. The information about us contained in this reoffer prospectus should be read together with the